Form 4: DarioHealth CEO Raphael Erez Acquires 5,000 Shares
SEC Form 4 Filing
DarioHealth Corp.'s CEO, Raphael Erez, purchased 5,000 shares of common stock at $0.88 per share on August 27, 2024.
Summary
- On August 27, 2024, Raphael Erez, the CEO of DarioHealth Corp., acquired 5,000 shares of the company's common stock.
- The purchase price was $0.88 per share.
- Following the transaction, Erez directly owns 1,937,059 shares of DarioHealth Corp.
- Erez also indirectly owns 37,876 shares through Dicilyon Consulting and Investment Ltd.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of insider trading activity. The CEO buying shares is generally seen as a positive sign, but without additional context, it's difficult to gauge the overall impact.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date of transaction: Raphael Erez purchased 5,000 shares of DarioHealth Corp. common stock. |
| 08/28/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.